Albuminuria

• 

  Subject Areas on Research

  • A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension. 
  • A role for the thromboxane receptor in L-NAME hypertension. 
  • A rose by any other name: is stage 3a chronic kidney disease really a disease? 
  • Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury. 
  • Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation. 
  • Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression. 
  • Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. 
  • Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. 
  • Albuminuria and Heart Failure: JACC State-of-the-Art Review. 
  • Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial. 
  • Albuminuria and kidney function as prognostic marker of left ventricular mass among South Asians with hypertension. 
  • Albuminuria in chronic heart failure: prevalence and prognostic importance. 
  • Albuminuria: is it time to screen the general population? 
  • Ambulatory blood pressure in the dash diet trial: Effects of race and albuminuria. 
  • Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study. 
  • Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults. 
  • Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study. 
  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. 
  • Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment. 
  • Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study. 
  • Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study. 
  • Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk. 
  • Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice. 
  • Biomarkers predict progression of acute kidney injury after cardiac surgery. 
  • Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease. 
  • C-reactive protein and microalbuminuria in a multi-ethnic Asian population. 
  • CUBN is a gene locus for albuminuria. 
  • Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. 
  • Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. 
  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. 
  • Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population. 
  • Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population. 
  • Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study. 
  • Cost-effectiveness of screening for proteinuria. 
  • Cytokine storm-based mechanisms for extrapulmonary manifestations of SARS-CoV-2 infection. 
  • Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations. 
  • Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. 
  • Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. 
  • Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial. 
  • Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. 
  • Enalapril and hydroxyurea therapy for children with sickle nephropathy. 
  • Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. 
  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. 
  • Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design. 
  • Extent of hypertension and renal injury in children surviving acute lymphoblastic leukemia. 
  • First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort. 
  • Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes. 
  • Gq signaling causes glomerular injury by activating TRPC6. 
  • High normal levels of albuminuria and risk of hypertension in Indo-Asian population. 
  • High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study. 
  • High-normal albuminuria and risk of heart failure in the community. 
  • Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. 
  • Impact of genetic background on nephropathy in diabetic mice. 
  • Impact of systemic vascular risk factors on the choriocapillaris using optical coherence tomography angiography in patients with systemic hypertension. 
  • Improving the prediction of hypertensive target organ damage using novel markers: lessons from retinal vascular imaging research. 
  • Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. 
  • Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP. 
  • Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. 
  • Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. 
  • Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment? 
  • Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab. 
  • Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. 
  • Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure. 
  • MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. 
  • Mechanisms of the proteinuria induced by Rho GTPases. 
  • Megalin/Cubulin-Lysosome-mediated Albumin Reabsorption Is Involved in the Tubular Cell Activation of NLRP3 Inflammasome and Tubulointerstitial Inflammation. 
  • Metabolic syndrome: definition, pathophysiology, and mechanisms. 
  • Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. 
  • Microalbuminuria predicts overt proteinuria among patients with HIV infection. 
  • Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus. 
  • Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. 
  • Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits. 
  • Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease. 
  • Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. 
  • Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL. 
  • Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study. 
  • Prevalence of apparent treatment-resistant hypertension among individuals with CKD. 
  • Prevalence of microalbuminuria and associated electrocardiographic abnormalities in an Indo-Asian population. 
  • Prevalence, trends and functional impairment associated with reduced estimated glomerular filtration rate and albuminuria among the oldest-old U.S. adults. 
  • Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study. 
  • Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction. 
  • Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? 
  • Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. 
  • Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. 
  • Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. 
  • Retinal microvascular caliber and chronic kidney disease in an Asian population. 
  • Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Role for thromboxane receptors in angiotensin-II-induced hypertension. 
  • Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension. 
  • Self-reported Age of Hypertension Onset and Hypertension-Mediated Organ Damage in Middle-Aged Individuals. 
  • Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes. 
  • Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease. 
  • Socioeconomic status and microalbuminuria in an Asian population. 
  • Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. 
  • Structural changes in the retinal microvasculature and renal function. 
  • Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. 
  • Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today. 
  • TRPC6 enhances angiotensin II-induced albuminuria. 
  • The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes. 
  • The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study. 
  • The association of systemic microvascular changes with lung function and lung density: a cross-sectional study. 
  • The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients. 
  • The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. 
  • The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background. 
  • The relationship between albuminuria and hypercholesterolemia. 
  • Urinary biomarkers indicate pediatric renal injury among rural farming communities in Sri Lanka. 
  • Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. 
  • Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. 
  • Use of glycated hemoglobin and microalbuminuria in the monitoring of diabetes mellitus. 
  • Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. 
  • Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. 
• 

  Keywords of People

  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology